TwinBeech Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.01M Buy
+11,689
New +$1.03M 0.23% 128
2026
Q1
– Sell
-6,841
Closed -$657K – 730
2025
Q4
$657K Buy
+6,841
New +$665K 0.05% 369
2025
Q2
– Sell
-25,611
Closed -$2.3M – 864
2025
Q1
$2.3M Sell
25,611
-535,791
-95% -$47.9M 0.04% 368
2024
Q4
$44.8M Buy
+561,402
New +$48.6M 0.77% 37
2023
Q3
– Sell
-98,915
Closed -$8.71M – 802
2023
Q2
$8.71M Buy
+98,915
New +$8.52M 0.17% 163
2023
Q1
– Sell
-190,002
Closed -$14.8M – 780
2022
Q4
$14.8M Sell
190,002
-10,408
-5% -$844K 0.28% 103
2022
Q3
$16.2M Buy
200,410
+29,329
+17% +$2.64M 0.43% 67
2022
Q2
$15.4M Buy
+171,081
New +$17.3M 0.69% 42
2022
Q1
– Sell
-83,369
Closed -$8.62M – 651
2021
Q4
$8.62M Buy
+83,369
New +$9.7M 0.49% 57
2020
Q4
– Sell
-24,417
Closed -$2.54M – 546
2020
Q3
$2.54M Buy
+24,417
New +$2.45M 0.55% 51
2020
Q1
– Sell
-26,354
Closed -$2.99M – 404
2019
Q4
$2.99M Buy
+26,354
New +$2.89M 0.87% 22

Other funds holding MDT

TwinBeech Capital's MDT Position: Q3 2026 in Review

TwinBeech Capital opened a new position in Medtronic (MDT) in Q3 2026: 11,689 shares worth $1.01M. The stake represents 0.23% of the portfolio and ranks #128 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in MDT as recently as Q4 2025.

TwinBeech Capital first reported a position in MDT in Q4 2019 and has held it in 11 quarters since. The position peaked at $44.8M in Q4 2024. 2,202 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • TwinBeech Capital held 11,689 shares of Medtronic worth $1.01M as of Q3 2026.
  • Medtronic was a new TwinBeech Capital position in Q3 2026.
  • Medtronic made up 0.23% of TwinBeech Capital's portfolio in Q3 2026, its #128 holding.
  • TwinBeech Capital first reported a position in Medtronic in Q4 2019 and has held it in 11 quarters since.
  • TwinBeech Capital's Medtronic position peaked at $44.8M in Q4 2024.
  • 2,202 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.